FI43622B - - Google Patents

Info

Publication number
FI43622B
FI43622B FI1517/67A FI151767A FI43622B FI 43622 B FI43622 B FI 43622B FI 1517/67 A FI1517/67 A FI 1517/67A FI 151767 A FI151767 A FI 151767A FI 43622 B FI43622 B FI 43622B
Authority
FI
Finland
Application number
FI1517/67A
Other languages
Finnish (fi)
Inventor
H Weber
A Molenaar
Original Assignee
Koninklijke Gist Spiritus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Gist Spiritus filed Critical Koninklijke Gist Spiritus
Application granted granted Critical
Publication of FI43622B publication Critical patent/FI43622B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI1517/67A 1966-05-31 1967-05-30 FI43622B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (de) 1966-05-31 1966-05-31

Publications (1)

Publication Number Publication Date
FI43622B true FI43622B (de) 1971-02-01

Family

ID=19796753

Family Applications (1)

Application Number Title Priority Date Filing Date
FI1517/67A FI43622B (de) 1966-05-31 1967-05-30

Country Status (22)

Country Link
US (1) US3557280A (de)
JP (1) JPS5010373B1 (de)
AT (1) AT272522B (de)
BE (1) BE699091A (de)
CH (1) CH490087A (de)
CS (1) CS151454B2 (de)
DE (1) DE1617576C3 (de)
DK (1) DK117587B (de)
ES (1) ES340956A1 (de)
FI (1) FI43622B (de)
FR (1) FR5953M (de)
GB (1) GB1131007A (de)
GR (1) GR33861B (de)
IL (1) IL28009A (de)
IT (1) IT1140250B (de)
LU (1) LU53788A1 (de)
MY (1) MY7100015A (de)
NL (1) NL6607516A (de)
NO (1) NO126298B (de)
SE (1) SE354417B (de)
SU (1) SU510986A3 (de)
YU (1) YU31326B (de)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5418330B2 (de) * 1973-03-16 1979-07-06
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
US3929989A (en) * 1974-06-14 1975-12-30 Wendt Lab Inc Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
GB1592053A (en) * 1976-12-16 1981-07-01 Norbrook Lab Ltd Oxytetracycline compositions
US4213963A (en) * 1978-12-14 1980-07-22 Janssen Pharmaceutica N.V. Fluspirilene-containing compositions
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
EP1666453A1 (de) 1999-09-14 2006-06-07 Trustees Of Tufts College Verfahren zur Herstellung von substituierten Tetracyclinen mit Hilfe von auf Übergangsmetalle basierten ChemienT
WO2001052858A1 (en) * 2000-01-24 2001-07-26 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
US6818634B2 (en) * 2000-03-31 2004-11-16 Paratek Pharmaceuticals, Inc. 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
EP1286954B1 (de) 2000-05-15 2004-04-14 Paratek Pharmaceuticals, Inc. 7-substituierte kondensierte ring-tetrazyclin- verbindungen
US20020128238A1 (en) * 2000-06-16 2002-09-12 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
CN102336679A (zh) 2000-07-07 2012-02-01 塔夫茨大学信托人 7-取代的四环素化合物
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
CN100473644C (zh) 2000-07-07 2009-04-01 塔夫茨大学信托人 9-取代的二甲胺四环素化合物
WO2002004405A2 (en) 2000-07-07 2002-01-17 Trustees Of Tufts College 13-substituted methacycline compounds
EP1303479B1 (de) 2000-07-07 2011-04-06 Trustees Of Tufts College 7-, 8- und 9-substitutierte tetracyclinverbindungen
AU2002250331A1 (en) * 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
JP2005506291A (ja) 2001-03-13 2005-03-03 パラテック ファーマシューティカルズ， インク． ７，９−置換テトラサイクリン化合物
WO2002072031A2 (en) 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
EP1379255A2 (de) 2001-03-14 2004-01-14 Paratek Pharmaceuticals, Inc. Substituierte tetracyclin-verbindungen als antimykotische mittel
CA2444899C (en) 2001-04-24 2011-06-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
EP2995610A1 (de) 2002-01-08 2016-03-16 Paratek Pharmaceuticals, Inc. 4-dedimethylamino-tetracyclin-verbindungen
EP2311451A1 (de) 2002-03-08 2011-04-20 Paratek Pharmaceuticals, Inc. Aminomethyl-substituierte Tetracyclin-Verbindungen
IL164180A0 (en) 2002-03-21 2005-12-18 Paratek Pharm Innc Substituted tetracycline compounds
CA2492273C (en) 2002-07-12 2013-02-05 Paratek Pharmaceuticals, Inc. 3, 10, and 12a substituted tetracycline compounds
EP2277504A1 (de) 2002-10-24 2011-01-26 Paratek Pharmaceuticals, Inc. Substituierte Tetracyclin-Verbindungen zur Behandlung von Malaria
JP2006514119A (ja) * 2003-02-12 2006-04-27 アール アンド ピー コリア カンパニー リミテッド 溶解率が向上した難溶性薬剤の溶媒系
EA201001081A1 (ru) * 2003-07-09 2011-02-28 Пэрэтек Фамэсьютикэлс, Инк. Соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
EP2292590A3 (de) 2003-07-09 2012-05-02 Paratek Pharmaceuticals, Inc. Prodrugs aus 9-Aminomethyl-Tetracyclinverbindungen
JP5010284B2 (ja) * 2004-01-15 2012-08-29 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物の芳香族ａ環誘導体
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
EP2301912A3 (de) 2004-10-25 2012-07-11 Paratek Pharmaceuticals, Inc. 4-Aminotetracycline und Verfahren zu ihrer Verwendung
EP2284156A3 (de) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Substituierte Tetracyclin-Verbindungen
JP2008530023A (ja) 2005-02-04 2008-08-07 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物の１１ａ，１２−誘導体
DE102005012595A1 (de) * 2005-03-18 2006-09-21 Lanxess Deutschland Gmbh Herstellung von Tri(chlorpropyl)phosphat
US20070093455A1 (en) * 2005-07-21 2007-04-26 Paul Abato 10-substituted tetracyclines and methods of use thereof
WO2007035448A2 (en) * 2005-09-19 2007-03-29 Albemarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
EP1991236A2 (de) 2006-01-24 2008-11-19 Paratek Pharmaceuticals, Inc. Verfahren zur erhöhung der oralen bioverfügbarkeit von tetracyclinen
US20070244335A1 (en) * 2006-04-17 2007-10-18 Teva Pharmaceutical Industries Ltd. Isolation of tetracycline derivatives
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
EP2857386B1 (de) * 2006-04-24 2017-02-22 Teva Pharmaceutical Industries Ltd Kristalline Tigecylinformen und Verfahren zur Herstellung davon
EP2431469A3 (de) * 2006-05-15 2012-05-30 Paratek Pharmaceuticals, Inc. Verfahren zur Regelung der Genexpression oder von Genprodukten mit substituierten Tetracyclinverbindungen
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
EP2452935A3 (de) 2006-12-21 2012-08-29 Paratek Pharmaceuticals, Inc. Tetracyxlin-Derivate zur Behandlung bakterieller, viraler und parasitärer Infektionen
CA2892739A1 (en) 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
EP2144614A1 (de) 2007-04-12 2010-01-20 Paratek Pharmaceuticals, Inc. Verfahren zur behandlung von spinaler muskelatrophie mittels tetracyclinverbindungen
AU2008246119A1 (en) * 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
BRPI0823405A2 (pt) 2007-07-06 2012-12-25 Paratek Pharm Innc mÉtodos para sintetizar compostos de tetraciclina substituÍda
WO2009111064A2 (en) 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Minocycline compounds and methods of use thereof
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
CA2721399A1 (en) * 2008-04-14 2009-10-22 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
TW202332671A (zh) 2008-05-23 2023-08-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
WO2010011522A1 (en) 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
EA201170425A1 (ru) * 2008-09-19 2011-10-31 Паратек Фармасьютикалс, Инк. Тетрациклиновые соединения для лечения ревматоидного артрита и связанные с ними способы лечения
AU2010233089B2 (en) 2009-04-10 2016-05-26 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (MMP-1)
EP3574908B8 (de) 2011-05-12 2024-09-11 Almirall LLC Pharmazeutische zubereiting für orale verabreichung mit kristallinen salzen von (4s, 4as, 5ar, 12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacen-2-carbonsäureamid
EP3534908A4 (de) 2016-11-01 2020-05-27 Paratek Pharmaceuticals, Inc. 9-aminomethyl-minocyclin-verbindungen und verwendung davon in der behandlung von ambulant erworbener bakterieller pneumonie (cabp)
JP2020527607A (ja) 2017-07-21 2020-09-10 アルミラール・リミテッド・ライアビリティ・カンパニーＡｌｍｉｒａｌｌ， Ｌｌｃ 非炎症性病変の処置

Also Published As

Publication number Publication date
FR5953M (de) 1968-04-16
NO126298B (de) 1973-01-22
IT1140250B (it) 1986-09-24
ES340956A1 (es) 1968-06-16
DK117587B (da) 1970-05-11
BE699091A (de) 1967-11-27
CS151454B2 (de) 1973-10-19
DE1617576A1 (de) 1972-04-27
YU31326B (en) 1973-04-30
MY7100015A (en) 1971-12-31
SE354417B (de) 1973-03-12
GR33861B (el) 1968-02-09
DE1617576B2 (de) 1980-04-10
SU510986A3 (ru) 1976-04-15
DE1617576C3 (de) 1980-12-11
LU53788A1 (de) 1967-07-31
JPS5010373B1 (de) 1975-04-21
IL28009A (en) 1970-08-19
NL6607516A (de) 1967-12-01
GB1131007A (en) 1968-10-16
US3557280A (en) 1971-01-19
AT272522B (de) 1969-07-10
CH490087A (de) 1970-05-15

Similar Documents

Publication Publication Date Title
FI43622B (de)
AT281852B (de)
AU5917865A (de)
AU428063B2 (de)
AU424443B2 (de)
AU421822B2 (de)
AU417216B2 (de)
AU433222B2 (de)
AU414526B2 (de)
AU415165B1 (de)
AU1144366A (de)
AU612166A (de)
AU218666A (de)
AU1111066A (de)
AU5895065A (de)
AU6703465A (de)
AU433620A (de)
AU6852465A (de)
BE675084A (de)
AU1027866A (de)
AU414093B2 (de)
AU411645B2 (de)
AU407778B2 (de)
AU2390066A (de)
BE690285A (de)